Top

Reactions Weekly

Published in:

01-06-2022 | Case report

Gemcitabine/nivolumab

Acute generalised exanthematous pustulosis: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Magdelaine P, et al. Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report. Thoracic Cancer : Jan 2022. Available from: URL: http://doi.org/10.1111/1759-7714.14405

Title: Gemcitabine/nivolumab
Acute generalised exanthematous pustulosis: case report
Publication date: 01-06-2022
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-17927-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Gemcitabine/nivolumab

Acute generalised exanthematous pustulosis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Bupivacaine/fentanyl

Clozapine

Epinephrine/lidocaine

Polyvalent antivenom

Cyclophosphamide/fludarabine/rituximab

Pembrolizumab